Quote Originally Posted by Alan Blood View Post
I found the oncotherm patent of Szasz at https://patents.google.com/patent/US9320911/en . They discuss a complex modulation involving some positive feedback from a sensor. I dont understand it all, but you could read it with the clue that the sensor unit is an SWR sensor. They mention 1/f pink noise. I am thinking the initial signal might be either clean sine or clean rectified sine ... and the shape of the mod signal is then further distorted or refined as a fourier sum (with some reference to the SWR feedback sensor input). It may be that the patent text does not clearly spell out the intention of the signal modification .... but it might be as simple as adding just enough odd harmonics (or pink number harmonics, whatever) to get optimal SWR, and it stops adding extra harmonics once this extra action makes SWR worse. If my guess is correct, there is no special clinical or physiological aspect to this signal shaping, but minimising carrier reflection might be clinically optimal anyway (or not). If the mod shape can impact on target impedance, then maybe that is like an electrical engineer's ecstatic experience of sacred geometry.

According to https://www.rife.de/oncotherm---rife...erthermia.html they changed the faceplate label from MOD to RIFE, perhaps because the Rife story is so popular.... but probably the invention is originally unrelated to Rife. There is a typo in the rife.de text. 1/3 should read 1/f.

Why would Szasz play with modulation in the first place ? Maybe because it allows higher peak RF power while limiting heating (related to average power). In older texts he used the term fractal modulation, which I beleive means like flower petals, but it may have some more obscure mathematical meaning.
Hi Alan,
as I know Prof. Szasz personally and spent hours talking to him over the years, let me correct a few things you said:

Prof. Szasz designed his Oncotherm units based on Rife research that he then further developed in a Hungarian university. He describes his methods as based on Rife, but a further development of it. RIFE was originally written on his units and that is what made me aware of them, when I saw them at the Medica trade fair in Germany. The term "Rife" was changed to "Modulation" due to negative comments from others that were made. The technology is the same, they just changed the word. They have done a number of clinical studies with their Oncothermia, which combines hyperthermia with Rife modulation and they have had proven results in the treatment of cancer. If you are looking for a company that has been involved in clinical studies, this is the one.
Szasz has told me many times that he learned a lot about Rife and that was the basis of his research that led to Oncotherm.